161 related articles for article (PubMed ID: 1463919)
1. Methods of monitoring menstrual function in field studies: efficacy of methods.
Kesner JS; Wright DM; Schrader SM; Chin NW; Krieg EF
Reprod Toxicol; 1992; 6(5):385-400. PubMed ID: 1463919
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
[TBL] [Abstract][Full Text] [Related]
3. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
4. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
Stanczyk FZ; Miyakawa I; Goebelsmann U
Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
6. Mean versus individual hormonal profiles in the menstrual cycle.
Alliende ME
Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
8. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
9. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
10. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
11. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
[TBL] [Abstract][Full Text] [Related]
12. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
13. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites.
Baird DD; McConnaughey DR; Weinberg CR; Musey PI; Collins DC; Kesner JS; Knecht EA; Wilcox AJ
Epidemiology; 1995 Sep; 6(5):547-50. PubMed ID: 8562634
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the OvuSTICK urinary luteinizing hormone kit in normal and stimulated menstrual cycles.
Elkind-Hirsch K; Goldzieher JW; Gibbons WE; Besch PK
Obstet Gynecol; 1986 Mar; 67(3):450-3. PubMed ID: 3511422
[TBL] [Abstract][Full Text] [Related]
15. Assessment of anovulation in eumenorrheic women: comparison of ovulation detection algorithms.
Lynch KE; Mumford SL; Schliep KC; Whitcomb BW; Zarek SM; Pollack AZ; Bertone-Johnson ER; Danaher M; Wactawski-Wende J; Gaskins AJ; Schisterman EF
Fertil Steril; 2014 Aug; 102(2):511-518.e2. PubMed ID: 24875398
[TBL] [Abstract][Full Text] [Related]
16. A prototype for ovulation detection: pros and cons.
Lasley BL; Shideler SE; Munro CJ
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
[TBL] [Abstract][Full Text] [Related]
18. [Effects of daily consumption of milk powder on menstrual cycles and urine sex hormone concentrations of young women].
Zhang M; Ju J; Wang Z; Wu J; Geng S; Liu J; Yang Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):754-8. PubMed ID: 25438529
[TBL] [Abstract][Full Text] [Related]
19. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements.
Behre HM; Kuhlage J; Gassner C; Sonntag B; Schem C; Schneider HP; Nieschlag E
Hum Reprod; 2000 Dec; 15(12):2478-82. PubMed ID: 11098014
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures.
De Souza MJ; Toombs RJ; Scheid JL; O'Donnell E; West SL; Williams NI
Hum Reprod; 2010 Feb; 25(2):491-503. PubMed ID: 19945961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
